ARTICLE INFO

Article Type

Original Research

Authors

Nakhzari Khodakheir   j. (*)
Haghighi   A.H. (1)
Hamedinia   M.R. (1)
Ahmadi   A. (1)






(*) Department of Sport Science, Faculty of Literature, Zabol University, Zabol, Iran
(1) Department of Sport Physiology, Faculty of Sport Sciences, Hakim Sabzevari University, Sabzevar, Iran

Correspondence

Address: Department of Sport Science, Faculty of Literature, Zabol University, Zabol, Iran
Phone: +98 915-939-5542
Fax: +98 54-322-35478
javadnakhzari@uoz.ac.ir

Article History

Received:   February  6, 2018
Accepted:   June 26, 2018
ePublished:   October 10, 2018

ABSTRACT

Aims Imbalance and disruption in daily functioning (sitting, standing up and walking) are major clinical symptoms of MS, while physical activity and exercise is an important non-pharmacological method in the rehabilitation and control of clinical signs of the disease.
Materials & Methods Combined exercise + Q10 and combined exercise groups performed a combined exercise program including two sessions of aerobic training (50 to 60 max HR at the beginning to the end) and one session of resistance training (50-60% 1RM from beginning to end) three sessions per week. Daily 200 mg of CoQ10 supplement was prescription in capsule form and starch was also used as placebo. Endurance and speed of walk were measured by using of up & go, 25 foot walking, 6 min walking and chair stand test before and after training protocol. Data were analyzed with analysis of covariance and t-test at a significance level of P<0.05.
Findings The results showed a significant decrease in the time of the standing and sitting tests, also a significant increase in endurance and speed of walking in combined exercise training + Q10 supplementation and combined exercise training groups versus Q10 supplementation and placebo groups.
Conclusion Combined exercise training with coenzyme Q10 supplementation or alone can lead to improved muscular function such as sitting, standing and walking in patient with MS. Therefore, this method can be used as a complementary tool in addition to drug therapy for the improvement of clinical symptoms of these patients.

Keywords: Multiple Sclerosis, Exercise training, Coenzyme Q10,

CITATION LINKS

[1]Bansi J, Bloch W, Gamper U, Kesselring J. Training in MS: Influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult Scler. 2013;19(5):613-62.
[2]Kjølhede T, Vissing K, Dalgas U. Multiple sclerosis and progressive resistance training: A systematic review. Mult Scler. 2012;18(9):1215-28.
[3]White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sport Med. 2004;34(15):1077-100.
[4]Harris VK, Sadiq SA. Disease Biomarkers in Multiple Sclerosis. Mol Diagn Ther. 2009;13(4):225-44.
[5]Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis-a quiet revolution. Nat Rev Neurol. 2015;11(33):134-42.
[6]Iran MS Society. The history of the establishment of the MS Association of Iran [Internet]. Tehran: Iran MS Society; 2017 [cited 2017 Dec 01]. Available from: http://www.iranms.ir/fa/page/10/
[7]Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol. 2007;61(4):288-99.
[8]Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious Factors. Ann Neurol. 2007;61(6):504-13.
[9]Motl RW. Lifestyle physical activity in persons with multiple sclerosis: The new kid on the MS block. Mult. Scler. 2014;20(8):1025-9.
[10]Van Emmerik RE, Remelius JG, Johnson MB, Chung LH, Kent-Braun JA. Postural control in women with multiple sclerosis: Effects of task, vision and symptomatic fatigue. Gait Posture. 2010;32(4):608-14.
[11]Wetzel JL, Fry DK, Pfalzer LA. Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: Performance and explanatory factors. Physiother Can. 2011;63(2):166-80.
[12]Bowser B, O'Rourke S, Brown CN, White L, Simpson KJ. Sit-to-stand biomechanics of individuals with multiple sclerosis. Clin Biomech (Bristol, Avon). 2015;30(8):788-94.
[13]Pearson M, Dieberg G, Smart N. Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis. Arch Phys Med Rehabil. 2015;96(7):1339-1348.e7.
[14]Dalgas U, Stenager E. Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis. Mult Scler. 2014;20(2):141-2.
[15]Tallner A, Waschbisch A, Wenny I, Schwab S, Hentschke C, Pfeifer K, et al. Multiple sclerosis relapses are not associated with exercise. Mult Scler. 2012;18(2):232-5.
[16]Courtney AM, Castro-Borrero W, Frohman TC, Frohman EM. Functional treatments in multiple sclerosis. Curr Opin Neurol. 2011;24(3):250-4.
[17]Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol. 1996;39(4):432-41.
[18]Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler. 2012;8(2):161-8.
[19]Newman MA, Dawes H, van den Berg M, Wade DT, Burridge J, Izadi H. Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: A pilot study. Mult Scler. 2007;13(1):113-9.
[20]Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G. Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Current Drug Targets. 2010;11(1):111-21.
[21]Potgieter M, Pretorius E, Pepper MS. Primary and secondary coenzyme Q10 deficiency: The role of therapeutic supplementation. Nutr Rev. 2013;71(3):180-8.
[22]Mohammadi-bardbori A, Hosseini MJ. Therapeutic implication of coenzyme Q10 during statin therapy: Pros and cons. Trends Pharma Sci. 2015;1(3):119-28.
[23]Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Jazayeri S, Reza Gohari M. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis. Int J Neurosci. 2013;123(11):776-82.
[24]Hathcock JN, Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regul Toxicol Pharmacol. 2006;45(3):282-8.
[25]Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial. Nutr Neurosci. 2016;19(3):138-43.
[26]Parsa N, Hosseini ZS. New Scientific Findings on Multiple Sclerosis Disease. Sci Cultiv. 2012;2(2):20-8. [Persian]
[27]Bernardi M, Rosponi A, Castellano V, Rodio A, Traballesi M, Delussu AS, et al. Determinants of sit-to-stand capability in the motor impaired elderly. J Electromyogr Kinesiol. 2004;14(3):401-10.
[28]Haghighi A, Heshmati Kia A, Hosseini Kakhak A. The effect of caffeine and ephedrine supplement and their combination on maximal stregnth and muscular endurance in male bodybuilders. J Sport Biosci. 2013;5(4):89-107. [Persian]
[29]Bennell K, Dobson F, Hinman R. Measures of physical performance assessments: Self-Paced Walk Test (SPWT), Stair Climb Test (SCT), Six-Minute Walk Test (6MWT), Chair Stand Test (CST), Timed Up & Go (TUG), Sock Test, Lift and Carry Test (LCT), and Car Task. Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S350-70.
[30]Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler. 2012;18(7):914-24.
[31]Romberg A, Virtanen A, Ruutiainen J, Aunola S, Karppi SL, Vaara M, et al. Effects of a 6-month exercise program on patients with multiple sclerosis: A randomized study. Neurology. 2004;63(11):2034-8.
[32]Romberg A, Virtanen A, Ruutiainen J. Long-term exercise improves functional impairment but not quality of life in multiple sclerosis. J Neurol. 2005;252(7):839-45.
[33]Dettmers C, Sulzmann M, Ruchay-Plössl A, Gütler R, Vieten M. Endurance exercise improves walking distance in MS patients with fatigue. Acta Neurol Scand. 2009;120(4):251-7.
[34]Sabapathy NM, Minahan CL, Turner GT, Broadley SA. Comparing endurance- and resistance-exercise training in people with multiple sclerosis: A randomized pilot study. Clin Rehabil. 2011;25(1):14-24.
[35]Collett J, Dawes H, Meaney A, Sackley C, Barker K, Wade D, et al. Exercise for multiple sclerosis: A single-blind randomized trialcomparing three exercise intensities. Mult Scler. 2011;17(5):594-603.
[36]Cakt BD, Nacir B, Genç H, Saraçoğlu M, Karagöz A, Erdem HR, et al. Cycling Cycling progressive resistance training for people with multiple sclerosis: A randomized controlled study. Am J Phys Med Rehabil. 2010;89(6):446-57.
[37]Kjølhede T, Vissing K, de Place L, Pedersen BG, Ringgaard S, Stenager E, et al. Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up. Mult Scler. 2015;21(5):599-611.
[38]Learmonth YC, Paul L, Miller L, Mattison P, McFadyen AK. The effects of a 12-week leisure centre-based, group exercise intervention for people moderately affected with multiple sclerosis: A randomized controlled pilot study. Clin Rehabil. 2012;26(7):579-93.
[39]Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology. 2009;73(18):1478-84.